News
04-30-2010, 03:43 AM
Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.
More... (http://www.news-medical.net/news/20100430/Study-confirms-MammaPrints-capabilities-in-determining-patients-likely-to-benefit-from-chemotherapy.aspx)
More... (http://www.news-medical.net/news/20100430/Study-confirms-MammaPrints-capabilities-in-determining-patients-likely-to-benefit-from-chemotherapy.aspx)